The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there is no substantial evidence that they directly increase the risk for vascular events.
Researchers analyzed autopsies of patients who died from COVID-19 to understand the pathophysiology of COVID-19-related myopathy.
Authors of a commentary assessed the role of IL-1 receptor antagonism, specifically anakinra, in the treatment of patients with severe COVID-19.
Study authors reviewed the literature to determine the effect of multimorbidity on all-cause mortality, functional status, and quality of life in RA.
According to this systematic review, sexual and gender minority patients may be at risk for several neurologic deficiencies.
Researchers assessed the association between inflammatory disease activity and incident diabetes mellitus in patients with rheumatoid arthritis.
Dr Amit Akirov examines the evidence suggesting associations between migraine and major depressive disorder (MDD).
The C-reactive protein to albumin ratio is a novel inflammation marker that may be a valuable predictor of coronary artery lesion formation in Kawasaki disease.
There were sustained benefits of early and continuous ocrelizumab on disease progression in primary progressive multiple sclerosis.
Researchers determined the causal associations between genetically predicted TNF-α, IL-12p70, and IL-17 levels and risk for psoriatic arthritis.
